BRK-A vs JCE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BRK-A shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Concerns include weak profitability or high valuation.
The deterministic health profile is severely compromised with a Piotroski F-Score of 1/9, indicating significant fundamental weakness. However, this is contrasted by a strong value proposition, with the stock trading at a P/E of 5.93 and below its intrinsic value of $18.90. While long-term price performance is robust (+72.6% over 5 years), the current technical trend is heavily bearish (10/100). The investment case rests on a high dividend yield of 8.49% and deep value, offset by poor short-term momentum and weak health metrics.
Compare Another Pair
Related Comparisons
BRK-A vs JCE: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-A) and Nuveen Core Equity Alpha Fund (JCE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.